Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 4, 1999, Pages 745-750

  Bundgaard, Henning ^a   Havndrup, Ole ^a   Andersen, Paal Skytt ^b   Larsen, Lars Allan ^b   Brandt, Niels Jacob ^b   Vuust, Jens ^b   Kjeldsen, Keld ^a   Christiansen, Michael ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

ATP binding; Hypertrophic cardiomyopathy; Mutation detection; Myosin structure and function; PCR SSCP; Sudden cardiac death

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGININE; MYOSIN HEAVY CHAIN; PROTEIN; THREONINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BINDING SITE; CLINICAL ARTICLE; ENERGY; FEMALE; HUMAN; HYDROLYSIS; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SARCOMERE; SCHOOL CHILD;

EID: 0033119752     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0911     Document Type: Article

References (34)

1. AL-MAHDAWI S, CHAMBERLAIN S, CHOJNOWSKA L, MICHALAK E, NIHOYANNOPOULOS P, RYAN M, KUSNIERCZYK B, FRENCH JA, GILLIGAN DM, CLELAND J, et al. 1994. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 72: 105-111.
2. BECKER KD, GOTTSHALL KR, HICKEY R, PERRIARD JC, CHIEN KR, 1997. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly. J Cell Biol 137: 131-140.
3. BONNE G, CARRIER L, BERCOVICI J, CRUAUD C, RICHARD P, HAINQUE B, GAUTEL M, LABEIT S, JAMES M, BECKMANN J, et al. 1995. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11: 438-440.
4. CHARRON P, CARRIER L, DUBOURG O, TESSON F, DESNOS M, RICHARD P, BONNE G, GUICHENEY P, HAINQUE B, BOUHOUR JB, et al. 1997a. Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 8: 107-114.
5. CHARRON P, DUBOURG O, DESNOS M, ISNARD R, HAGEGE A, MILLAIRE A, CARRIER L, BONNE G, TESSON F, RICHARD P, et al. 1997b. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96: 214-219.
6. CUDA G, FANANAPAZIR L, EPSTEIN ND, SELLERS JR, 1997. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil 18: 275-283.
7. DIMITROW PP, CZARNECKA D, JASZCZ KK, DUBIEL JS, 1997. Sex differences in age at onset of symptoms in patients with hypertrophic cardiomyopathy. J Cardiovasc Risk 4: 33-35.
8. DUFOUR C, DAUSSE E, FETLER L, DUBOURG O, BOUHOUR JB, VOSBERG HP, GUICHENEY P, KOMAJDA M, SCHWARTZ K, 1994. Identification of a mutation near a functional site of the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J Mol Cell Cardiol 26: 1241-1247.
9. FANANAPAZIR L, DALAKAS MC, CYRAN F, COHN G, EPSTEIN ND, 1993. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci 90: 3993-3997.
10. HAGEGE A, DESNOS M, MARIÉ F, DUBURG O, ISNARD R, CARRIER L, BOUHOUR J, SCHWARTZ K, KOMAJDA M, 1997. Could hypertrophy appear during adulthood in familial hypertrophic cardiomyopathy? Observation of a large cohort of genotypoed subjects. Circulation 94 (Suppl): I-501.
11. JAENICKE T, DIEDERICH KW, HAAS W, SCHLEICH J, LICHTER P, PFORDT M, BACH A, VOSBERG HP, 1990. The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics 8: 194-206.
12. KIMURA A, HARADA H, PARK JE, NISHI H, SATOH M, TAKAHASHI M, HIROI S, SASAOKA T, OHBUCHI N, NAKAMURA T, et al. 1997. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379-382.
13. MACRAE CA, GHAISAS N, KASS S, DONNELLY S, BASSON CT, WATKINS HC, ANAN R, THIERFELDER LH, MCGARRY K, ROWLAND E, et al. 1995. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 96: 1216-1220.
14. MARIAN AJ, ROBERTS R, 1995. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 92: 1336-1347.
15. MARON BJ, GOTTDIENER JS, EPSTEIN SE, 1981. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48: 418-428.
16. MARON BJ, GARDIN JM, FLACK JM, GIDDING SS, KUROSAKI TT, BILD DE, 1995. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92: 785-789.
17. MCKENNA WJ, SPIRITO P, DESNOS M, DUBOURG O, KOMAJDA M, 1997. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77: 130-132.
18. OHSUZU F, KATSUSHIKA S, AKANUMA M, NAKAMURA H, HARADA H, SATOH M, HIROI S, KIMURA A, 1997. Hypertrophic obstructive cardiomyopathy due to a novel T-to-A transition at codon 624 in the beta-myosin heavy chain (beta-MHC) gene possibly related to the sudden death. Int J Cardiol 62: 203-209.
19. POETTER K, JIANG H, HASSANZADEH S, MASTER SR, CHANG A, DALAKAS MC, RAYMENT I, SELLERS JR, FANANAPAZIR L, EPSTEIN ND, 1996. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63-69.
20. RAYMENT I, RYPNIEWSKI WR, SCHMIDT BASE K, SMITH R, TOMCHICK DR, BENNING MM, WINKELMANN DA, WESENBERG G, et al. 1993. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261: 50-58.
21. RAYMENT I, HOLDEN HM, SELLERS JR, FANANAPAZIR L, EPSTEIN ND, 1995. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci 92: 3864-3868.
22. ROBBINS J, 1996. Hypertrophic cardiomyopathy: a case study in converging pathways. J Clin Invest 98: 2433-2434.
23. RYAN MP, CLELAND JG, FRENCH JA, JOSHI J, CHOUDHURY L, CHOJNOWSKA L, MICHALAK E, AL-MAHDAWI S, NIHOYANNOPOULOS P, OAKLEY CM, 1995. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 76: 689-694.
24. SATA M, IKEBE M, 1996. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. J Clin Invest 98: 2866-2873.
25. SCHWARTZ K, CARRIER L, GUICHENEY P, KOMAJDA M, 1995. Molecular basis of familial cardiomyopathies. Circulation 91: 532-540.
26. SWEENEY HL, STRACESKI AJ, LEINWAND LA, TIKUNOV BA, FAUST L, 1994. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 269: 1603-1605.
27. TEN CATE FJ, HUGENHOLTZ PG, VAN DORP WG, ROELANDT J, 1979. Prevalence of dignostic abnormalities in patients with genetically transmitted asymmetric septal hypertrophy. Am J Cardiol 43: 731-737.
28. VIKSTROM KL, LEINWAND LA, 1996. Contractile protein mutations and heart disease. Curr Opin Cell Biol 8: 97-105.
29. WALSH PS, METZGER DA, HIGUCHI R, 1991. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10: 506-513.
30. WATKINS H, ROSENZWEIG A, HWANG DS, LEVI T, MCKENNA W, SEIDMAN CE, SEIDMAN JG, 1992. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108-1114.
31. WATKINS H, CONNER D, THIERFELDER L, JARCHO JA, MACRAE C, MCKENNA WJ, MARON BJ, SEIDMAN JG, SEIDMAN CE, 1995a. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11: 434-437.
32. WATKINS H, MCKENNA WJ, THIERFELDER L, SUK HJ, ANAN R, O'DONOGHUE A, SPIRITO P, MATSUMORI A, MORAVEC CS, SEIDMAN JG, SEIDMAN CE, 1995b. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058-1064.
33. WATKINS H, SEIDMAN CE, SEIDMAN JG, FENG HS, SWEENEY HL, 1996. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest 98: 2456-2461.
34. WATKINS H, SEIDMAN JG, SEIDMAN CE, 1995. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 4: 1721-1727.